Special Report: HER2 and Trastuzumab in Breast Cancer
August 3rd 2011The recognition and description of tumor growth control factors, together with the development of interventions that modulate their biologic activity, represent a major focus for current cancer research, which already has changed the practice of clinical oncology.
Read More